Medical Care

Global Blepharitis Market Research Report 2025

The global market for Blepharitis was valued at US$ 1641 million in the year 2024 and is projected to reach a revised size of US$ 2194 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Blepharitis is an inflammation of the eyelids in which they become red, irritated and itchy and dandruff-like scales form on the eyelashes. It is a common eye disorder caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. It affects people of all ages. Although uncomfortable, blepharitis is usually not contagious and generally does not cause any permanent damage to eyesight.
Market competition is intense. Bausch Health, Allergan, Novartis LABORATORIES THEA, etc. are the leaders of the industry. They hold key technologies and patents, with high-end customers, but only occupied 24.39% market share.
This report aims to provide a comprehensive presentation of the global market for Blepharitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blepharitis.
The Blepharitis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blepharitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blepharitis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Allergan
Novartis
LABORATORIES THEA
Akorn
NovaBay Pharmaceuticals
Scope Ophthalmics
Segment by Type
Antibiotics
Steroids
Other
Segment by Application
Monotherapy
Combination Drug Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blepharitis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blepharitis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotics
1.2.3 Steroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global Blepharitis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Monotherapy
1.3.3 Combination Drug Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blepharitis Market Perspective (2020-2031)
2.2 Global Blepharitis Growth Trends by Region
2.2.1 Global Blepharitis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blepharitis Historic Market Size by Region (2020-2025)
2.2.3 Blepharitis Forecasted Market Size by Region (2026-2031)
2.3 Blepharitis Market Dynamics
2.3.1 Blepharitis Industry Trends
2.3.2 Blepharitis Market Drivers
2.3.3 Blepharitis Market Challenges
2.3.4 Blepharitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blepharitis Players by Revenue
3.1.1 Global Top Blepharitis Players by Revenue (2020-2025)
3.1.2 Global Blepharitis Revenue Market Share by Players (2020-2025)
3.2 Global Blepharitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blepharitis Revenue
3.4 Global Blepharitis Market Concentration Ratio
3.4.1 Global Blepharitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blepharitis Revenue in 2024
3.5 Global Key Players of Blepharitis Head office and Area Served
3.6 Global Key Players of Blepharitis, Product and Application
3.7 Global Key Players of Blepharitis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blepharitis Breakdown Data by Type
4.1 Global Blepharitis Historic Market Size by Type (2020-2025)
4.2 Global Blepharitis Forecasted Market Size by Type (2026-2031)
5 Blepharitis Breakdown Data by Application
5.1 Global Blepharitis Historic Market Size by Application (2020-2025)
5.2 Global Blepharitis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blepharitis Market Size (2020-2031)
6.2 North America Blepharitis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blepharitis Market Size by Country (2020-2025)
6.4 North America Blepharitis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blepharitis Market Size (2020-2031)
7.2 Europe Blepharitis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blepharitis Market Size by Country (2020-2025)
7.4 Europe Blepharitis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blepharitis Market Size (2020-2031)
8.2 Asia-Pacific Blepharitis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blepharitis Market Size by Region (2020-2025)
8.4 Asia-Pacific Blepharitis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blepharitis Market Size (2020-2031)
9.2 Latin America Blepharitis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blepharitis Market Size by Country (2020-2025)
9.4 Latin America Blepharitis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blepharitis Market Size (2020-2031)
10.2 Middle East & Africa Blepharitis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blepharitis Market Size by Country (2020-2025)
10.4 Middle East & Africa Blepharitis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Blepharitis Introduction
11.1.4 Bausch Health Revenue in Blepharitis Business (2020-2025)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Blepharitis Introduction
11.2.4 Allergan Revenue in Blepharitis Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Blepharitis Introduction
11.3.4 Novartis Revenue in Blepharitis Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 LABORATORIES THEA
11.4.1 LABORATORIES THEA Company Details
11.4.2 LABORATORIES THEA Business Overview
11.4.3 LABORATORIES THEA Blepharitis Introduction
11.4.4 LABORATORIES THEA Revenue in Blepharitis Business (2020-2025)
11.4.5 LABORATORIES THEA Recent Development
11.5 Akorn
11.5.1 Akorn Company Details
11.5.2 Akorn Business Overview
11.5.3 Akorn Blepharitis Introduction
11.5.4 Akorn Revenue in Blepharitis Business (2020-2025)
11.5.5 Akorn Recent Development
11.6 NovaBay Pharmaceuticals
11.6.1 NovaBay Pharmaceuticals Company Details
11.6.2 NovaBay Pharmaceuticals Business Overview
11.6.3 NovaBay Pharmaceuticals Blepharitis Introduction
11.6.4 NovaBay Pharmaceuticals Revenue in Blepharitis Business (2020-2025)
11.6.5 NovaBay Pharmaceuticals Recent Development
11.7 Scope Ophthalmics
11.7.1 Scope Ophthalmics Company Details
11.7.2 Scope Ophthalmics Business Overview
11.7.3 Scope Ophthalmics Blepharitis Introduction
11.7.4 Scope Ophthalmics Revenue in Blepharitis Business (2020-2025)
11.7.5 Scope Ophthalmics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Blepharitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibiotics
Table 3. Key Players of Steroids
Table 4. Key Players of Other
Table 5. Global Blepharitis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Blepharitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Blepharitis Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Blepharitis Market Share by Region (2020-2025)
Table 9. Global Blepharitis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Blepharitis Market Share by Region (2026-2031)
Table 11. Blepharitis Market Trends
Table 12. Blepharitis Market Drivers
Table 13. Blepharitis Market Challenges
Table 14. Blepharitis Market Restraints
Table 15. Global Blepharitis Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Blepharitis Market Share by Players (2020-2025)
Table 17. Global Top Blepharitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blepharitis as of 2024)
Table 18. Ranking of Global Top Blepharitis Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Blepharitis Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Blepharitis, Headquarters and Area Served
Table 21. Global Key Players of Blepharitis, Product and Application
Table 22. Global Key Players of Blepharitis, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Blepharitis Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Blepharitis Revenue Market Share by Type (2020-2025)
Table 26. Global Blepharitis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Blepharitis Revenue Market Share by Type (2026-2031)
Table 28. Global Blepharitis Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Blepharitis Revenue Market Share by Application (2020-2025)
Table 30. Global Blepharitis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Blepharitis Revenue Market Share by Application (2026-2031)
Table 32. North America Blepharitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Blepharitis Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Blepharitis Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Blepharitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Blepharitis Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Blepharitis Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Blepharitis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Blepharitis Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Blepharitis Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Blepharitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Blepharitis Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Blepharitis Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Blepharitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Blepharitis Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Blepharitis Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bausch Health Company Details
Table 48. Bausch Health Business Overview
Table 49. Bausch Health Blepharitis Product
Table 50. Bausch Health Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 51. Bausch Health Recent Development
Table 52. Allergan Company Details
Table 53. Allergan Business Overview
Table 54. Allergan Blepharitis Product
Table 55. Allergan Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 56. Allergan Recent Development
Table 57. Novartis Company Details
Table 58. Novartis Business Overview
Table 59. Novartis Blepharitis Product
Table 60. Novartis Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. LABORATORIES THEA Company Details
Table 63. LABORATORIES THEA Business Overview
Table 64. LABORATORIES THEA Blepharitis Product
Table 65. LABORATORIES THEA Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 66. LABORATORIES THEA Recent Development
Table 67. Akorn Company Details
Table 68. Akorn Business Overview
Table 69. Akorn Blepharitis Product
Table 70. Akorn Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 71. Akorn Recent Development
Table 72. NovaBay Pharmaceuticals Company Details
Table 73. NovaBay Pharmaceuticals Business Overview
Table 74. NovaBay Pharmaceuticals Blepharitis Product
Table 75. NovaBay Pharmaceuticals Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 76. NovaBay Pharmaceuticals Recent Development
Table 77. Scope Ophthalmics Company Details
Table 78. Scope Ophthalmics Business Overview
Table 79. Scope Ophthalmics Blepharitis Product
Table 80. Scope Ophthalmics Revenue in Blepharitis Business (2020-2025) & (US$ Million)
Table 81. Scope Ophthalmics Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
Table 85. Authors List of This Report


List of Figures
Figure 1. Blepharitis Picture
Figure 2. Global Blepharitis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blepharitis Market Share by Type: 2024 VS 2031
Figure 4. Antibiotics Features
Figure 5. Steroids Features
Figure 6. Other Features
Figure 7. Global Blepharitis Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Blepharitis Market Share by Application: 2024 VS 2031
Figure 9. Monotherapy Case Studies
Figure 10. Combination Drug Therapy Case Studies
Figure 11. Blepharitis Report Years Considered
Figure 12. Global Blepharitis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Blepharitis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Blepharitis Market Share by Region: 2024 VS 2031
Figure 15. Global Blepharitis Market Share by Players in 2024
Figure 16. Global Top Blepharitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blepharitis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Blepharitis Revenue in 2024
Figure 18. North America Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Blepharitis Market Share by Country (2020-2031)
Figure 20. United States Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Blepharitis Market Share by Country (2020-2031)
Figure 24. Germany Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Blepharitis Market Share by Region (2020-2031)
Figure 32. China Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Blepharitis Market Share by Country (2020-2031)
Figure 40. Mexico Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Blepharitis Market Share by Country (2020-2031)
Figure 44. Turkey Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Blepharitis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bausch Health Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 48. Allergan Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 50. LABORATORIES THEA Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 51. Akorn Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 52. NovaBay Pharmaceuticals Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 53. Scope Ophthalmics Revenue Growth Rate in Blepharitis Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies